Age at onset in Huntington's disease: Replication study on the associations of ADORA2A, HAP1 and OGG1

Neurogenetics

Volumn 11, Issue 4, 2010, Pages 435-439

  Taherzadeh Fard, Elahe ^a   Saft, Carsten ^b   Wieczorek, Stefan ^a   Epplen, Jörg T ^a   Arning, Larissa ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

Age at onset; Huntington disease; Modifier genes; Polymorphism

Indexed keywords

8 HYDROXYGUANINE; ADENOSINE A2A RECEPTOR; DNA GLYCOSYLTRANSFERASE; HUNTINGTIN; HUNTINGTIN ASSOCIATED PROTEIN 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC ASSOCIATION; GERMANY; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MOTOR DYSFUNCTION; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; REPLICATION STUDY;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ALLELES; COGNITION; COHORT STUDIES; DNA GLYCOSYLASES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; HUNTINGTON DISEASE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; RECEPTOR, ADENOSINE A2A; RISK;

EID: 78650059716     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-010-0248-3     Document Type: Article

References (21)

1. Gusella JF, Macdonald ME (2009) Huntington's disease: the case for genetic modifiers. Genome Med 1:80
2. Arning L, Kraus PH, Valentin S, Saft C, Andrich J, Epplen JT (2005) NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. Neurogenetics 6:25-28
3. Andresen JM, Gayán J, Cherny SS, Brocklebank D, Alkorta- Aranburu G, Addis EA, US-Venezuela Collaborative Research Group, Cardon LR, Housman DE, Wexler NS (2007) Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds. J Med Genet 44:44-50
4. Weydt P, Soyal SM, Gellera C, Didonato S, Weidinger C, Oberkofler H, Landwehrmeyer GB, Patsch W (2009) The gene coding for PGC-1alpha modifies age at onset in Huntington's disease. Mol Neurodegener 4:3
5. Taherzadeh-Fard E, Saft C, Andrich J, Wieczorek S, Arning L (2009) PGC-1alpha as modifier of onset age in Huntington disease. Mol Neurodegener 4:10
6. Dhaenens CM, Burnouf S, Simonin C, Van Brussel E, Duhamel A, Defebvre L, Duru C, Vuillaume I, Cazeneuve C, Charles P, Maison P, Debruxelles S, Verny C, Gervais H, Azulay JP, Tranchant C, Bachoud-Levi AC, Dürr A, Buée L, Krystkowiak P, Sablonnière B, Blum D, Huntington French Speaking Network (2009) A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease. Neurobiol Dis 35:474-476
7. Metzger S, Rong J, Nguyen HP, Cape A, Tomiuk J, Soehn AS, Propping P, Freudenberg-Hua Y, Freudenberg J, Tong L, Li SH, Li XJ, Riess O (2008) Huntingtin- associated protein-1 is a modifier of the age-at-onset of Huntington's disease. Hum Mol Genet 17:1137-1146
8. Coppedè F, Migheli F, Ceravolo R, Bregant E, Rocchi A, Petrozzi L, Unti E, Lonigro R, Siciliano G, Migliore L (2009) The hOGG1 Ser326Cys polymorphism and Huntington's disease. Toxicology. doi:10.1016/j.tox.2009.10.019
9. Li XJ, Li SH, Sharp AH, Nucifora FC Jr, Schilling G, Lanahan A, Worley P, Snyder SH, Ross CA (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378:398-402
10. Wu LL, Zhou XF (2009) Huntingtin associated protein 1 and its functions. Cell Adh Migr 3:71-76
11. Li SH, Hosseini SH, Gutekunst CA, Hersch SM, Ferrante RJ, Li XJ (1998) A human HAP1 homologue. Cloning, expression, and interaction with huntingtin. J Biol Chem 273:19220-19227
12. Wu LL, Fan Y, Li S, Li XJ, Zhou XF (2010) Huntingtinassociated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release. J Biol Chem 285:5614-5623
13. Kovtun IV, Liu Y, Bjoras M, Klungland A, Wilson SH, McMurray CT (2007) OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 447:447-452
14. Boiteux S, Radicella JP (2000) The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys 377:1-8
15. Chen SK, Hsieh WA, Tsai MH, Chen CC, Hong AI, Wei YH, Chang WP (2003) Age-associated decrease of oxidative repair enzymes human 8-oxoguanine DNA glycosylases (OGG1), in human aging. J Radiat Res (Tokyo) 44:31-35
16. Janssen K, Schlink K, Götte W, Hippler B, Kaina B, Oesch F (2001) DNA repair activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is not dependent on genetic polymorphism Ser326/Cys326. Mutat Res 486:207-216
17. Lee AJ, Hodges NJ, Chipman JK (2005) Interindividual variability in response to sodium dichromate-induced oxidative DNA damage: role of the Ser326Cys polymorphism in the DNA-repair protein of 8-oxo-7, 8-dihydro-2'-deoxyguanosine DNA glycosylase 1. Cancer Epidemiol Biomark Prev 14:497-505
18. Bravard A, Vacher M, Moritz E, Vaslin L, Hall J, Epe B, Radicella JP (2009) Oxidation status of human OGG1-S326C polymorphic variant determines cellular DNA repair capacity. Cancer Res 69:3642-3649
19. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225-2229
20. Childs E, Hohoff C, Deckert J, Xu K, Badner J, de Wit H (2008) Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 33:2791-2800
21. Mai M, Akkad AD, Wieczorek S, Saft C, Andrich J, Kraus PH, Epplen JT, Arning L (2006) No association between polymorphisms in the BDNF gene and age at onset in Huntington disease. BMC Med Genet 7:79